 Maheen Abidi
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytomegalovirus Infections | 5 | 2024 | 187 | 3.210 |
Why?
| | Transplant Recipients | 6 | 2024 | 148 | 2.560 |
Why?
| | Hematopoietic Stem Cell Transplantation | 7 | 2023 | 540 | 1.710 |
Why?
| | Bacteremia | 3 | 2016 | 161 | 1.350 |
Why?
| | Cord Blood Stem Cell Transplantation | 2 | 2023 | 96 | 1.020 |
Why?
| | Voriconazole | 2 | 2015 | 24 | 1.010 |
Why?
| | Antifungal Agents | 2 | 2015 | 134 | 0.960 |
Why?
| | Immune Reconstitution | 1 | 2023 | 6 | 0.930 |
Why?
| | Transplantation Conditioning | 3 | 2019 | 156 | 0.820 |
Why?
| | Immunocompromised Host | 3 | 2016 | 200 | 0.720 |
Why?
| | Toxoplasmosis | 1 | 2019 | 31 | 0.710 |
Why?
| | Myocarditis | 1 | 2020 | 95 | 0.680 |
Why?
| | Cytomegalovirus | 3 | 2024 | 144 | 0.670 |
Why?
| | Organ Transplantation | 2 | 2020 | 165 | 0.640 |
Why?
| | Mucormycosis | 2 | 2015 | 20 | 0.640 |
Why?
| | Lung Transplantation | 1 | 2019 | 263 | 0.610 |
Why?
| | Tissue Donors | 1 | 2019 | 336 | 0.610 |
Why?
| | DNA, Viral | 1 | 2019 | 356 | 0.580 |
Why?
| | Virus Diseases | 1 | 2019 | 198 | 0.570 |
Why?
| | Micrococcaceae | 1 | 2016 | 1 | 0.560 |
Why?
| | Liver Transplantation | 2 | 2020 | 847 | 0.530 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2015 | 21 | 0.530 |
Why?
| | Aspergillus fumigatus | 1 | 2015 | 21 | 0.530 |
Why?
| | Aspergillosis | 1 | 2015 | 24 | 0.530 |
Why?
| | Neutropenia | 1 | 2016 | 133 | 0.520 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2016 | 67 | 0.520 |
Why?
| | Echinocandins | 1 | 2014 | 8 | 0.510 |
Why?
| | Amphotericin B | 1 | 2014 | 31 | 0.500 |
Why?
| | Helicobacter | 1 | 2013 | 5 | 0.450 |
Why?
| | Fever of Unknown Origin | 1 | 2013 | 7 | 0.450 |
Why?
| | Helicobacter Infections | 1 | 2013 | 25 | 0.450 |
Why?
| | Antiviral Agents | 4 | 2023 | 654 | 0.430 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 642 | 0.410 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 334 | 0.390 |
Why?
| | Stem Cell Transplantation | 3 | 2016 | 153 | 0.360 |
Why?
| | HIV Infections | 1 | 2024 | 2459 | 0.360 |
Why?
| | Hematologic Neoplasms | 4 | 2019 | 133 | 0.340 |
Why?
| | Middle Aged | 13 | 2020 | 27617 | 0.330 |
Why?
| | Humans | 23 | 2024 | 118972 | 0.260 |
Why?
| | Aged | 9 | 2022 | 19657 | 0.260 |
Why?
| | Anti-Bacterial Agents | 4 | 2019 | 1510 | 0.250 |
Why?
| | Male | 14 | 2024 | 57801 | 0.250 |
Why?
| | Adult | 11 | 2024 | 31512 | 0.230 |
Why?
| | Muscles | 1 | 2024 | 333 | 0.220 |
Why?
| | Hematology | 1 | 2022 | 12 | 0.220 |
Why?
| | Young Adult | 5 | 2019 | 10793 | 0.220 |
Why?
| | Graft vs Host Disease | 2 | 2015 | 216 | 0.220 |
Why?
| | Candidiasis, Invasive | 1 | 2021 | 5 | 0.210 |
Why?
| | Retrospective Studies | 6 | 2024 | 12978 | 0.200 |
Why?
| | Antibodies, Viral | 1 | 2024 | 542 | 0.190 |
Why?
| | Female | 12 | 2024 | 61564 | 0.190 |
Why?
| | Q Fever | 1 | 2019 | 6 | 0.180 |
Why?
| | Immunoglobulin G | 1 | 2024 | 788 | 0.180 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2019 | 37 | 0.180 |
Why?
| | Endocarditis, Bacterial | 1 | 2019 | 37 | 0.180 |
Why?
| | Chemoprevention | 1 | 2019 | 89 | 0.170 |
Why?
| | Fatal Outcome | 1 | 2019 | 287 | 0.170 |
Why?
| | Clostridium Infections | 1 | 2019 | 57 | 0.170 |
Why?
| | Pneumonia, Bacterial | 1 | 2019 | 110 | 0.170 |
Why?
| | Vancomycin | 1 | 2019 | 79 | 0.160 |
Why?
| | Liver Cirrhosis | 1 | 2020 | 245 | 0.160 |
Why?
| | Immunologic Factors | 1 | 2020 | 225 | 0.160 |
Why?
| | Telomerase | 1 | 2020 | 207 | 0.160 |
Why?
| | Transplantation, Homologous | 2 | 2015 | 415 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 521 | 0.140 |
Why?
| | Neoplasms | 2 | 2021 | 2179 | 0.140 |
Why?
| | Registries | 1 | 2024 | 1810 | 0.140 |
Why?
| | Inactivation, Metabolic | 1 | 2015 | 10 | 0.130 |
Why?
| | Morbidity | 1 | 2016 | 296 | 0.130 |
Why?
| | Antilymphocyte Serum | 1 | 2014 | 66 | 0.130 |
Why?
| | Rare Diseases | 1 | 2015 | 113 | 0.130 |
Why?
| | Mycophenolic Acid | 1 | 2014 | 79 | 0.120 |
Why?
| | Treatment Failure | 1 | 2015 | 341 | 0.120 |
Why?
| | Mortality | 1 | 2016 | 299 | 0.120 |
Why?
| | Gastrointestinal Diseases | 1 | 2015 | 187 | 0.120 |
Why?
| | History, 21st Century | 1 | 2014 | 170 | 0.120 |
Why?
| | Tacrolimus | 1 | 2014 | 151 | 0.120 |
Why?
| | Kidney Transplantation | 1 | 2019 | 585 | 0.110 |
Why?
| | Fungi | 1 | 2014 | 123 | 0.110 |
Why?
| | Lymphocytes | 1 | 2015 | 347 | 0.110 |
Why?
| | DNA, Ribosomal | 1 | 2013 | 79 | 0.110 |
Why?
| | Common Variable Immunodeficiency | 1 | 2013 | 27 | 0.110 |
Why?
| | Liver Failure | 1 | 2013 | 85 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2513 | 0.100 |
Why?
| | DNA, Bacterial | 1 | 2013 | 314 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 965 | 0.100 |
Why?
| | Cell- and Tissue-Based Therapy | 2 | 2022 | 54 | 0.100 |
Why?
| | Comorbidity | 1 | 2016 | 1527 | 0.100 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2013 | 514 | 0.090 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 681 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 755 | 0.090 |
Why?
| | Mutation | 1 | 2020 | 3457 | 0.090 |
Why?
| | Incidence | 1 | 2016 | 2424 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2871 | 0.080 |
Why?
| | Risk Factors | 2 | 2016 | 9000 | 0.070 |
Why?
| | Child, Preschool | 1 | 2019 | 9491 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2016 | 6561 | 0.060 |
Why?
| | Child | 2 | 2022 | 19129 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2016 | 9342 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2020 | 81 | 0.050 |
Why?
| | Adolescent | 1 | 2019 | 18480 | 0.050 |
Why?
| | Triazoles | 1 | 2021 | 134 | 0.050 |
Why?
| | Disinfection | 1 | 2020 | 108 | 0.040 |
Why?
| | Acetates | 1 | 2019 | 98 | 0.040 |
Why?
| | Quinazolines | 1 | 2019 | 245 | 0.040 |
Why?
| | Fetal Blood | 1 | 2019 | 272 | 0.040 |
Why?
| | United States | 1 | 2014 | 12555 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 278 | 0.040 |
Why?
| | Administration, Oral | 1 | 2019 | 756 | 0.040 |
Why?
| | Disease Management | 1 | 2020 | 571 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2015 | 136 | 0.030 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2015 | 109 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1774 | 0.030 |
Why?
| | Unrelated Donors | 1 | 2014 | 38 | 0.030 |
Why?
| | Abdominal Pain | 1 | 2015 | 133 | 0.030 |
Why?
| | Vaccination | 1 | 2022 | 1222 | 0.030 |
Why?
| | Fever | 1 | 2015 | 283 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1355 | 0.030 |
Why?
| | Kidney | 1 | 2019 | 1353 | 0.030 |
Why?
| | Recurrence | 1 | 2015 | 975 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1384 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3057 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2436 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1868 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6412 | 0.020 |
Why?
| | Lung | 1 | 2021 | 3664 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4596 | 0.020 |
Why?
| | Cohort Studies | 1 | 2015 | 5116 | 0.020 |
Why?
|
|
Abidi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|